期刊文献+

通痹汤联合非甾体抗炎药治疗强直性脊柱炎临床研究

Clinical Efficacy of Tongbi Soup Combined with Nonsteroidal Anti-inflammatory Drug for Patients with Ankylosing Spondylitis
下载PDF
导出
摘要 目的:探讨通痹汤联合非甾体抗炎药对强直性脊柱炎患者的临床疗效。方法:选取50例强直性脊柱炎患者,随机分为对照组和实验组各25例。对照组患者给予非甾体抗炎药治疗,实验组患者在对照组治疗基础上加服通痹汤,比较两组患者相关临床指标与总体治疗效果。结果:两组患者治疗后BASDAI指数、BASFI指数、VAS评分、晨僵时间与中医证候评分组间比较差异具有统计学意义(P<0.01);实验组患者总有效率明显高于对照组,差异具有统计学意义(P<0.05)。结论:通痹汤联合非甾体抗炎药对强直性脊柱炎临床疗效显著,值得临床推广应用。 Objective:To investigate the clinical efficacy of Tong Bi decoction combined with non steroidal anti--inflammatory drugs in patients with ankylosing spondylitis. Methods: 50 cases of ankylosing spondylitis patients were randomly divided into control group and experimental group of 25 cases. Patients in the control group were treated with non steroidal anti-inflammatory drugs, the experimental group patients in the control group treatment based on the treatment of Tong Bi soup, comparison of the two groups of patients with clinical indicators and the overall treatment effect. Results : After treatment, the patients in the two groups index BAS- DAI, BASFI index, VAS score, time of morning stiffness and TCM syndrome score between groups difference has statistical significance (P〈0.05) ;patients in the experimental group the total efficiency was significantly higher than that of the control group, the difference has statistical significance(P〈0. 05). Conclusion: Tong Bi decoction combined with non steroidal anti inflammatory drugs on ankylosing spondylitis clinical curative effect is significant, worthy of clinical application.
作者 尧建刚
出处 《亚太传统医药》 2016年第3期120-121,共2页 Asia-Pacific Traditional Medicine
关键词 强直性脊柱炎 通痹汤 非甾体抗炎药 临床研究 Ankylosing Spondylitis Tong Bi Tang Non Steroidal Anti-inflammatory Clinical Research
  • 相关文献

参考文献4

二级参考文献44

  • 1龚晓明,任凯.针灸疗法在强直性脊柱炎康复治疗中的系统评价[J].中国康复医学杂志,2007,22(6):537-539. 被引量:9
  • 2van der Heijde D, Landew6 R, Einstein S, et al. Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept. Arthritis Rheum,2008,58:1324-1331.
  • 3Wanders A, Heijde Dr, Landew6 R, et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum, 2005,52 : 1756-1765.
  • 4Braun J, van den Berg R, Baraliakos X, et al. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis ,2011,70:896-904.
  • 5Boersma JW. Retardation of ossification of the lumbar vertebral column in ankylosing spondylitis by means of phenylbutazone. Seand J Rheumatol, 1976,5:60-64.
  • 6Poddubnyy D, Rudwaleit M, Haibel H, et al. Effect of non- steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort. Ann Rheum Dis, 2012,71: 1616-1622.
  • 7Bauer DC, Orwoll ES, Fox KM, et al. Aspirin and NSAID use in older women: effect on bone mineral density and fracture risk. Study of Osteoporotic Fractures Research Group. J Bone Miner Res, 1996,11:29-35.
  • 8Richards JB, Joseph L, Schwartzman K, et al. The effect of cyclooxygenase-2 inhibitors on bone mineral density: results from the Canadian Multicentre Osteoporosis Study. Osteoporos Int, 2006,17 : 1410-1419.
  • 9Bonewald LF, Johnson ML. Osteocytes, mechanosensing and Wnt signaling. Bone, 2008,42:606-615.
  • 10Sakuma Y, Tanaka K, Suda M, et al. Impaired bone resorption by lipopolysaccharide in vivo in mice deficient in the prostaglandin E receptor EP4 subtype. Infect lmmun,2000,68:6819-6825.

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部